Pfizer Inc. has announced that it has reached an agreement with AstraZeneca for the acquisition of the development and commercialization rights to its late-stage small molecule anti-infectives business. Read More »
TG Therapeutics Inc. recently announced that it has received orphan drug designation for TG-1101, otherwise known as ublituximab, from the U.S. Food and Drug Administration (FDA). Read More »
Phase III trial produces positive results in treating primary biliary cholangitis with Ocaliva. Read More »
Pfizer Inc. has announced that analysis of data from three studies involving VYNDAQEL have been published. Read More »
Bamboo research is focused on gene therapy for neuromuscular and central nervous system conditions. Read More »
Argentum Pharmaceuticals recently announced that it, along with its manufacturing partner KVK Tech, has been granted a petition for inter partes review (IPR) against all challenged claims of the sole patent that covers Alcon’s PAZEO by the U.S. Patent & Trademark Office (PTO). Read More »
Galmed Pharmaceuticals has announced that Professor Ran Oren, M.D., has been named its Chief Medical Officer (CMO). Read More »
Pfizer Inc. recently announced that its third Phase III study of XELJANZ (tofacitinib citrate), Oral Clinical Trials for tofacitinib in ulcerative colitis (OCTAVE) Sustain, has turned in positive result Read More »
Pfizer Inc. recently published the findings from two pivotal Phase III studies of crisaborole topical ointment 2 percent, formerly known as AN2728. Read More »
Galmed Pharmaceuticals Ltd. and SAMIL Pharm. Co.recently announced that a license agreement has been put into place for an exclusive, royalty-bearing license for Aramchol and its commercialization. Read More »
Cancer vaccine WO-12 to be developed by Pfizer and Western Oncolytics. Read More »
.jpg)
Spark Therapeutics and Pfizer Inc. recently announced that SPK-9001 has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA). Read More »
The World Health Organization (WHO) this week prequalified the four-dose, multi-dose vial (MDV) for Pfizer Inc.’s Prevenar 13. Read More »
Pfizer announces positive results from year-long S-TRAC trial of SUTENT. Read More »
FDA approves expanded age range for the pneumonia vaccine. Read More »
SPIRE-HR and SPIRE-FH lipid-lowering studies meet primary endpoints. Read More »
Nielsen recognizes brands that sustain more than $50 million in first year of sales and maintain 90 percent of the sales level in second year. Read More »
Pfizer Inc. recently announced its completed acquisition of Anacor Pharmaceuticals, Inc., giving each outstanding Anacor common stock share the opportunity to gain $99.25 net in cash as part of the acquisition. Read More »
Britol-Myers Squibb recently appointed Murdo Gordon its new EVP and chief commercial officer. Read More »
The Pfizer Get Old community and Idiegogo's entrepreneurs invited to submit products or services that support healthy aging. Read More »
Alerts Sign-up
